Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,176Revenue $M1.5Net Margin (%)-7,181.0Altman Z-Score44.8
Enterprise Value $M1,058EPS $-1.0Operating Margin %-7,580.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-4.1Pre-tax Margin (%)-7,181.0Higher ROA y-yN
Price/Book10.710-y EBITDA Growth Rate %-13.2Quick Ratio9.4Cash flow > EarningsY
Price/Sales8995-y EBITDA Growth Rate %-0.1Current Ratio9.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-134.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-160.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M128ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2015-06-30 Sold Out -0.01%$8.81 - $12.5
($10.36)
$ 8.99-13%Sold Out0
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 8.99-9%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 8.99386%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 8.99103%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.12-11.17view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.7-7.32view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.65-6.84view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.752.74view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.5156.86view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.272.88view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9980.16view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9282.72view
Fowler WycheDirector 2011-08-10Buy5,000$5.1973.22view
KIRK RANDAL JDirector, 10% Owner 2011-08-09Buy846,522$4.7888.08view

Quarterly/Annual Reports about ZIOP:

    News about ZIOP:

    Articles On GuruFocus.com
    Holdings Aug 02 2015 
    Intrexon Corp is expanding his business Jun 25 2015 
    Holdings Mar 31 2015 
    Holdings Mar 31 2015 
    Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
    Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
    comment on ZIOP Mar 15 2013 
    cooldecency99 note on ZIOP May 01 2010 
    ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs Aug 14 2009 

    More From Other Websites
    ZIOPHARM ONCOLOGY INC Financials Aug 21 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Aug 21 2015
    10-Q for ZIOPHARM Oncology, Inc. Aug 12 2015
    Ziopharm reports 2Q loss Aug 10 2015
    Ziopharm reports 2Q loss Aug 10 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 10 2015
    ZIOPHARM Reports Second-Quarter 2015 Financial Results and Recent Activities Aug 10 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly Report Aug 10 2015
    Intrexon Announces Second Quarter and First Half 2015 Financial Results Aug 10 2015
    ZIOPHARM Announces Orphan Drug Designation for Ad-RTS-hIL-12 in the Treatment of Malignant Glioma Jul 24 2015
    Will ZIOPHARM Oncology (ZIOP) Stock Decline After Analyst Downgrade? Jun 22 2015
    Ziopharm Oncology Downgraded By BMO As 'Questions Persist' Jun 22 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 19 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 18 2015
    Here’s why some investors think Ziopharm is poised for a $10B merger Jun 11 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial... Jun 08 2015
    Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares Jun 05 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 02 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK